Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-07-30

Clinical Trial Update: Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Antigen Pulsed Dendritic Cells (APDC) in metastatic colorectal cancer; the current trial status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antigen Pulsed Dendritic Cells (APDC)

Snippet

Sponsor: Second Military Medical University | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: UNKNOWN